Polypeptides and antibodies derived from chronic lymphocytic...

Details Polypeptides and antibodies derived from chronic lymphocytic... Polypeptides and antibodies derived from chronic lymphocytic...

C - Chemistry, Metallurgy

07

K

C07K 16/30 (2006.01) A61K 39/395 (2006.01) A61P 35/00 (2006.01) G01N 33/53 (2006.01)

Patent

CA 2517968

Methods for administering polypeptides, including antibodies, capable of binding to OX-2/CD200 and/or an OX-2/CD200 receptor are disclosed. These polypeptides are useful in treating disease states characterized by upregulated levels of OX-2/CD200, including cancer and CLL.

L'invention concerne des méthodes destinées à administrer des polypeptides, et notamment des anticorps, pouvant se lier à OX-2/CD200 et/ou à un récepteur d'OX-2/CD200. Ces polypeptides sont utiles dans le traitement d'états pathologiques caractérisés par des taux régulés positivement d'OX-2/CD200, tels que le cancer et la leucémie lymphocytique chronique.

Affiliated with

Also associated with

Rating

Polypeptides and antibodies derived from chronic lymphocytic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polypeptides and antibodies derived from chronic lymphocytic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptides and antibodies derived from chronic lymphocytic... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1752313